Objective. Regulated in development and DNA damage response 1 (REDD1) is an endogenous inhibitor of mechanistic target of rapamycin (mTOR) that regulates cellular stress responses. REDD1 expression is decreased in aged and osteoarthritic (OA) cartilage, and it regulates mTOR signaling and autophagy in articular chondrocytes in vitro. This study was undertaken to investigate the effects of REDD1 deletion in vivo using a mouse model of experimental OA.
Objective. Regulated in development and DNA damage response 1 (REDD1) is an endogenous inhibitor of mechanistic target of rapamycin (mTOR) that regulates cellular stress responses. REDD1 expression is decreased in aged and osteoarthritic (OA) cartilage, and it regulates mTOR signaling and autophagy in articular chondrocytes in vitro. This study was undertaken to investigate the effects of REDD1 deletion in vivo using a mouse model of experimental OA.
Methods. OA severity was histologically assessed in 4-month-old wild-type and REDD1
2/2 mice subjected to surgical destabilization of the medial meniscus (DMM). Chondrocyte autophagy, apoptosis, mitochondrial content, and expression of mitochondrial biogenesis markers were determined in cartilage and cultured chondrocytes from wild-type and REDD1 2/2 mice. Results. REDD1 deficiency increased the severity of changes in cartilage, menisci, subchondral bone, and synovium in the DMM model of OA. Chondrocyte death was increased in the cartilage of REDD1 2/2 mice and in cultured REDD1 2/2 mouse chondrocytes under oxidative stress conditions. Expression of key autophagy markers (microtubule-associated protein 1A/1B light chain 3 and autophagy protein 5) was markedly reduced in cartilage from REDD1
2/2 mice and in cultured human and mouse chondrocytes with REDD1 depletion. Mitochondrial content, ATP levels, and expression of the mitochondrial biogenesis markers peroxisome proliferator-activated receptor g coactivator 1a (PGC-1a) and transcription factor A, mitochondrial (TFAM) were also decreased in REDD1-deficient chondrocytes. REDD1 was required for AMPactivated protein kinase-induced PGC-1a in chondrocytes.
Conclusion. Our findings suggest that REDD1 is a key mediator of cartilage homeostasis through regulation of autophagy and mitochondrial biogenesis and that REDD1 deficiency exacerbates the severity of injury-induced OA.
Osteoarthritis (OA) is the most prevalent joint disease and causes pain and disability (1) . Although OA is considered a disease of the whole synovial joint, degradation of articular cartilage is a critical event in disease initiation and progression. Cartilage damage is a result of an imbalance between anabolic and catabolic processes that compromise the function of articular chondrocytes, the cells that maintain tissue homeostasis (2) . OA is a multifactorial disease, and aging is its main risk factor (2) . Despite the fact that not all persons develop OA with age, there are significant agerelated changes in articular cartilage that may serve as a basis for OA development (3) . These changes include reduced thickness and cell density, abnormal secretory activity, cell senescence, and defective cellular defense mechanisms (3) . Understanding the molecular mechanisms that drive cartilage aging has become a main focus of OA research.
Macroautophagy (hereinafter referred to as autophagy) is a conserved process that recycles defective cellular organelles and macromolecules and is activated during hypoxic and energy stress to provide energy for the cell (4). Our group has shown that autophagy is constitutively active in articular chondrocytes and that there is a reduction in the expression of key autophagy markers during aging and OA (5) . A major regulator of autophagy is the serine/threonine kinase mechanistic target of rapamycin (mTOR) (6) . Under nutrient-replete conditions, mTOR suppresses autophagy through phosphorylation of Unc-51-like kinase 1 and autophagy protein 13 (ATG-13) (6). As part of the normal cellular response to stress, endogenous regulators such as FOXO, AMP-activated protein kinase (AMPK), or regulated in development and DNA damage response 1 (REDD1) inhibit mTOR to arrest cell growth and proliferation while enhancing stress resistance and cell survival (6) . However, these regulatory mechanisms seem to be defective in articular cartilage during aging and OA. We and others have reported a reduction in FOXO, AMPK, and REDD1 expression and activity in cartilage during aging and OA (7) (8) (9) (10) , and there is evidence of increased mTOR expression in OA cartilage (11) . Moreover, genetic or pharmacologic inhibition of mTOR signaling results in autophagy activation and protection against experimental OA in mice (11, 12) . These findings suggest that increased mTOR signaling may compromise autophagy in chondrocytes and contribute to the development of OA.
REDD1 (encoded by DDIT4) is an evolutionarily conserved protein that is ubiquitously expressed in adult tissue and regulates cellular stress responses. REDD1 expression is induced by hypoxia and other stresses (13, 14) and acts primarily as a canonical mTOR inhibitor (15) (16) (17) . Interestingly, REDD1 regulates autophagy through an mTORindependent mechanism that involves a direct interaction with thioredoxin-interacting protein to induce reactive oxygen species (ROS) production and activation of ATG-4B, a key component of the autophagic machinery (18) . We have previously reported that REDD1 is abundantly expressed in human and mouse knee articular cartilage and that its expression is reduced during aging and OA (10) . Moreover, REDD1 positively regulates autophagy in human and mouse articular chondrocytes, also in an mTOR-independent manner (10) , suggesting that reduced REDD1 expression in cartilage may contribute to the increased mTOR activity and autophagy deficiency that are characteristic of OA pathophysiology.
The present study was designed to evaluate the role of REDD1 in OA development in vivo using a mouse model of experimental OA. Our results show that genetic disruption of REDD1 impairs autophagy in cartilage and exacerbates the severity of experimental OA. Furthermore, we identified a novel function of REDD1 as a regulator of mitochondrial biogenesis in articular chondrocytes.
MATERIALS AND METHODS
Mice. All animal experiments were performed in compliance with protocols approved by the Institutional Animal Care and Use Committee at The Scripps Research Institute. Global REDD1-knockout mice (REDD1
2/2
) on a C57BL/6J background (19) are the property of Quark Pharmaceuticals, were provided by the company, and were generated specifically for Quark by Lexicon Genetics. For examination of joint and skeletal development and of growth and maturation, mice were euthanized after 7 days (on postnatal day 7), or at 1, 2, or 6 months of age. For aging studies, wild-type mice were euthanized at 6 or 27 months of age. For the surgical OA model, 4-month-old male mice (n 5 12 per genotype) were anesthetized, and transection of the medial meniscotibial ligament (destabilization of the medial meniscus [DMM] ) and the medial collateral ligament was performed in the right knee as previously described (12, 20) . For a control, sham surgery was performed on the left knee and consisted of a small incision in the medial side, opening of the joint capsule, and closing with surgical suture. Animals were euthanized 10 weeks after surgery, and knee joints were embedded in a standardized fixed angle of the femur relative to the tibia so that the sections that were scored represented the center of the weight-bearing areas of the tibial plateau and femoral condyle (9) .
Five-micrometer-thick sagittal sections of the medial compartment of the knee were stained with Safranin O-fast green (9) , and OA-related changes were scored in one section per animal as previously described for articular cartilage (summed Osteoarthritis Research Society International [OARSI] score for femur and tibia) (21), synovium (22) , anterior and posterior meniscal horns (23) , and subchondral bone (24) . Samples were graded by 2 individuals who were blinded with regard to mouse genotype.
Mouse cell culture. Immature mouse articular chondrocytes were isolated from the knees and hips of 6-day-old wildtype and REDD1 2/2 mice (19) following the protocol described by Gosset et al (25) . Synovial membranes were obtained from the knee joints of 4-month-old REDD1 1/1 and REDD1 2/2 mice (n 5 4 per genotype), and synoviocytes were isolated after a 4-hour digestion with collagenase (2 mg/ml; Sigma) at 378C. Cells were maintained in medium containing 10% calf serum, and second-passage cells were plated at a density of 10 5 cells/ml, incubated overnight, and treated for 24 hours with tert-butyl-hydroperoxide (tBHP; Sigma), 1 nM interleukin-1b (IL-1b; PeproTech), chloroquine (25 mM; Sigma), or 1 mM 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR; Sigma) as indicated.
Human chondrocyte culture. Human primary chondrocytes were isolated as previously described (8) and maintained in Dulbecco's modified Eagle's medium containing 10% calf serum at 378C in 5% CO 2 . First-passage chondrocytes were used in all experiments. For REDD1 knockdown, chondrocytes were grown to confluence and transfected with small interfering RNA (siRNA) for DDIT4/REDD1 (Life Technologies) using Lipofectamine RNAiMAX (Life Technologies) in media containing 1% calf serum for 48 hours.
Immunohistochemistry. Paraffin-embedded knees from REDD1 1/1 mice were processed as previously described (9), and sections were incubated overnight with antibodies against REDD1 (1:100; Proteintech), microtubule-associated protein 1A/1B light chain 3 (LC3) (1:50; MBL), or ATG-5 (1:100, Abcam). After washing with phosphate buffered saline (PBS), sections were incubated for 30 minutes with ImmPRESS-AP anti-rabbit IgG polymer detection reagent (Vector), dehydrated, and mounted. Positive cells were quantified in the articular cartilage and both meniscal horns of the proximal tibial plateau in 2 different pictures per section taken at 203 magnification. Results are reported as the percentage of immunopositive cells.
TUNEL staining. Five-micrometer-thick sections were digested with pepsin (Dako) for 8 minutes at 378C, and endogenous peroxidase was blocked using Vector's Bloxall solution at room temperature for 10 minutes. TUNEL staining was completed using an in situ detection kit with fluorescein (Roche). Cartilage cellularity and TUNEL-positive cells were measured in 2 different fields per section, and results are expressed as cells per mm 2 and percentage of fluorescent cells, respectively. Cell viability. Articular chondrocytes from REDD1
and REDD1 2/2 mice were cultured in 96-well plates and treated with the oxidant tBHP at 0, 50, 100, or 250 mM for 24 hours. Cell viability was assessed using a RealTime-Glo MT Cell Viability Assay (Promega). Four independent experiments were performed in triplicate. Results are expressed as relative cell viability with respect to untreated chondrocytes from REDD1
1/1 mice. Intracellular ATP measurement. Mouse articular chondrocytes were cultured in 96-well plates in media containing 25 mM glucose or galactose for 24 hours, and intracellular ATP levels were measured using a CellTiter-Glo assay (Promega).
DNA isolation and mitochondrial DNA (mtDNA) quantification. Knee cartilage, spleen, and brain were collected from 6-month-old mice, flash-frozen in liquid nitrogen, and DNA was isolated using a Blood and Tissue DNA isolation kit (Qiagen). To quantify mtDNA content, quantitative polymerase chain reaction (qPCR) was performed for mtDNA-encoded cytochrome c oxidase subunit 2 (MT-CO2) and nucleus-encoded 18S ribosomal DNA as previously described (26) . The MT-CO2:18S ratio represents the relative mtDNA copy number (26) .
RNA isolation and gene expression analysis. Mouse and human cartilage were homogenized in QIAzol Lysis Reagent (Qiagen), and RNA was isolated using an RNeasy Mini kit (Qiagen). In cultured cells, RNA was collected using a Direct-zol RNA Miniprep kit (Zymo Research).
Gene expression was measured by qPCR using predesigned TaqMan gene expression assays for MAP1LC3, ATG5, PPARGC1A, and TFAM. GAPDH was measured as a reference gene.
Protein isolation and Western blotting. Cultured cells were washed twice in PBS and lysed in ice-cold radioimmunoprecipitation assay buffer (Pierce) supplemented with protease and phosphatase inhibitor cocktail (Thermo Scientific). Twenty micrograms of protein was resolved in 4-12% acrylamide gels, transferred to nitrocellulose membranes, and blotted overnight with antibodies against REDD1 (1:500; Proteintech), cleaved caspase 3 (1:500; Cell Signaling Technology), LC3 (1:1,000; Cell Signaling Technology), p62 (1:1,000; Cell Signaling Technology), oxidative phosphorylation cocktail (1:1,000; Abcam), peroxisome proliferator-activated receptor g coactivator 1a (PGC-1a) (1:1,000; BioVision), transcription factor A, mitochondrial (TFAM) (1:500; Cell Signaling Technology), and GAPDH (1:5,000; Abcam). After incubating with secondary antibodies for 1 hour at room temperature, blots were visualized using a Li-Cor Odyssey infrared imaging system. Intensity values were analyzed using ImageStudioLite software and normalized to those of GAPDH.
Statistical analysis. Data are shown as the mean 6 SD. Differences between groups were assessed by one-way analysis of variance followed by a post hoc Tukey test. Comparisons between 2 groups were assessed by an unpaired, 2-tailed t-test after testing for equal variance using an F test. All statistical analyses were performed using Prism 6 software (GraphPad). P values less than 0.05 were considered significant.
RESULTS
Normal embryonic skeletal development and postnatal growth and maturation in REDD1-deficient mice. Mice with global deletion of REDD1 developed normally and had similar weight and length as their wild-type littermates (see Supplementary Figure 1 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley. com/doi/10.1002/art.40104/abstract). Histologic analysis of the knees showed no differences in articular cartilage morphology between REDD1
1/1 and REDD1 2/2 mice up to 6 months of age. Increased OA severity in mice deficient in REDD1.
To evaluate the role of REDD1 in cartilage homeostasis during OA pathogenesis, we induced OA in REDD1 2/2 and wild-type mice by DMM. REDD1 2/2 mice showed increased articular cartilage degradation and had significantly higher histopathologic scores than wild-type mice 10 weeks after DMM surgery (P , 0.001) (Figure 1 ). In addition, REDD1 2/2 mice had significantly higher synovitis scores (P , 0.001) with increased synovial hyperplasia and abundant cell infiltration, increased meniscus degeneration (P 5 0.006) with loss of meniscus cells and Safranin O staining and partial erosion of tissue, and more severe bone pathology (P , 0.001) with thickening of subchondral bone, reduction of medullary cavities, and increased osteophyte formation (Figure 1) .
Reduced REDD1 expression in aging mouse joint tissue. REDD1 deficiency resulted in widespread pathologic changes in the joint during experimental OA. Our previous work focused on articular cartilage only, and we showed decreased expression of REDD1 with aging (10) . In this study, we sought to evaluate the changes in REDD1 expression during aging in different tissues of the knee joint from 6-and 27-month-old mice. Histologic analysis of knees from older mice revealed OA-like changes with aging that resulted in significantly increased histopathologic scores compared with young controls (Figure 2A) . Immunohistochemical staining for REDD1 was abundant in the cartilage, meniscus, and synovium of 6-month-old mice. However, REDD1 expression was significantly reduced in the articular cartilage and medial meniscus of 27-month-old mice when compared with 6-monthold controls ( Figure 2B) , and a similar reduction in REDD1 staining was observed in the synovium.
Increased chondrocyte death in REDD1-deficient mice. Chondrocyte death following injury is a pivotal event that is closely linked to cartilage degradation (27) . We next evaluated whether REDD1 deficiency altered chondrocyte viability. TUNEL staining revealed an increased rate of chondrocyte apoptosis in the knee articular cartilage of REDD1 2/2 mice compared with controls, and there was a concomitant reduction in cartilage cellularity (P , 0.001) (Figures 3A and B) . To test whether articular chondrocytes with REDD1 depletion are more susceptible to apoptotic cell death, cultured primary chondrocytes from REDD1 2/2 and wild-type mice were treated with increasing concentrations of tBHP to induce oxidative stress ( Figure 3C ). Cells from mutant mice showed significantly higher rates of cell death than wild-type cells and a significant increase in cleaved caspase 3, an indicator of apoptotic cell death ( Figure 3D ). In addition, REDD1-deficient chondrocytes exhibited a significant reduction in the expression of key antioxidant genes (FoxO3, Hmox1, and Sesn2) when treated with tBHP as compared with wild-type cells ( Figure 3E ). In contrast, REDD1 deficiency did not alter IL-1b-induced expression of inflammatory mediators or apoptosis induction by tBHP (data not shown). Taken together, these results indicate that articular chondrocytes lacking REDD1 are more susceptible to apoptotic cell death under oxidative stress. REDD1 deficiency reduces autophagy protein expression. The levels of 2 key autophagy proteins, LC3 and ATG-5, were significantly lower in the cartilage of 6-month-old REDD1 2/2 mice than wild-type mice ( Figure  4A ). No differences in LC3 or ATG-5 expression were seen in the medial meniscus ( Figure 4B ) or synovium (Supplementary Figure 2A , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.40104/abstract). In cultured primary chondrocytes, LC3 and ATG-5 messenger RNA (mRNA) levels were significantly lower in cells from REDD1 2/2 mice compared with wild-type cells ( Figure 4C ), and this effect was mimicked by siRNA-mediated REDD1 knockdown in human articular chondrocytes ( Figure 4D ), but it was not present in primary mouse synoviocytes (Supplementary Figure 2B) . In addition, autophagy flux analysis by Western blotting revealed a significant reduction in LC3 processing and p62 protein levels in REDD1-deficient chondrocytes compared with wild-type cells under normal and stress conditions ( Figure 4E ). These results suggest that REDD1 is a key regulator of articular cartilage autophagy in vivo and in vitro.
REDD1 controls mitochondrial biogenesis through PGC-1a signaling. It has recently been reported that REDD1 deficiency results in accumulation of dysfunctional mitochondria (18) . We measured the levels of mtDNA and nuclear DNA in the cartilage of REDD1 2/2 and wild-type mice to estimate the number of mitochondria. Surprisingly, whereas there was a significant increase in the ratio of mtDNA to nuclear DNA in the spleen and brain of mutant mice, consistent with previous reports (18), we found a marked reduction in mtDNA in the cartilage of REDD1 2/2 mice ( Figure 5A ), suggesting that REDD1 controls mitochondrial number in a tissue-specific manner. Moreover, REDD1
2/2 primary chondrocytes had significantly lower mtDNA content ( Figure 5B ), mitochondrial complex proteins ( Figure 5C ), and ATP levels ( Figure 5D ) than wildtype mouse cells.
These findings prompted us to investigate whether mitochondrial biogenesis was impaired in the absence of REDD1. REDD1 2/2 mouse chondrocytes, but not synoviocytes, had significantly lower levels of mRNA for Pgc1a and Tfam, 2 key regulators of mitochondrial biogenesis ( Figure 5E and Supplementary Figure 2C) . PGC-1a protein levels were also reduced in chondrocytes from mutant mice (Figure 5F ), but not in synoviocytes (Supplementary Figure 2D ). In a similar manner, knockdown of REDD1 in cultured human articular chondrocytes resulted in a significant decrease in PGC-1a and TFAM mRNA and protein levels ( Figures 5G and H) . These data indicate that REDD1 controls mitochondrial biogenesis in articular chondrocytes through transcriptional regulation of PGC-1a and TFAM.
AMPK signaling is known to act upstream of PGC1a to promote mitochondrial biogenesis and regulate energy metabolism (28) . To elucidate whether AMPK signaling is involved in REDD1-induced PGC-1a expression, levels of p-AMPK were measured in cultured chondrocytes from REDD1
1/1 and REDD1 2/2 mice by Western blotting. Chondrocytes from mutant mice showed higher levels of p-AMPK than control cells ( Figure 6A ). Upon treatment with AICAR, p-AMPK levels were similar in REDD1 1/1 and REDD1 2/2 mouse chondrocytes ( Figure  6B ), indicating that REDD1 is not required for AMPK activation by AICAR. However, AMPK activation induced expression of PGC-1a and TFAM mRNA ( Figure 6C ) and protein levels ( Figure 6D ) in normal chondrocytes but not in REDD1-deficient cells. These findings suggest that REDD1 acts downstream of AMPK and is required for AMPK-mediated transcriptional control of PGC-1a.
DISCUSSION
The main finding of the present study is that REDD1 deficiency increases the severity of experimental OA in mice. Articular cartilage damage was more severe in REDD1
2/2 mice than in wild-type mice, and similar differences were observed in the synovium, meniscus, and subchondral bone. These findings are of particular relevance in the context of joint aging, since REDD1 expression is reduced in human and mouse cartilage (10) and in mouse meniscus and synovium with age.
Another important finding of this study is that cartilage cellularity in REDD1 2/2 mice was significantly reduced. Extensive death of chondrocytes is a hallmark of posttraumatic OA pathophysiology and is linked to tissue damage (29) (30) (31) . After the initial injury that leads to disruption of the cartilage matrix and death of chondrocytes in the affected area, multiple factors are generated in response to the trauma that can contribute to the activation of apoptotic pathways, further extending the zone of chondrocyte death. These factors include inflammatory cytokines, ROS, nitric oxide, and various damageassociated molecular patterns (32, 33) .
Our data showed that REDD1 preserves chondrocyte viability in vivo and in vitro and supports the notion that this function of REDD1 partly mediates the effects of REDD1 in posttraumatic OA. While the precise molecular mechanisms underlying this function of REDD1 in cartilage remain to be entirely elucidated, our data support the role of REDD1 as an important survival factor against oxidative stress in chondrocytes by activating the expression of important antioxidant genes and protecting cells against apoptotic cell death. Consistent with this finding, it has been reported that a fraction of REDD1 is located in the mitochondria, and that mitochondrial localization is required for REDD1 to suppress mitochondrial ROS production (34) . REDD1-deficient murine embryonic fibroblasts exhibit increased levels of ROS, and ectopic expression of REDD1 is sufficient to normalize cellular ROS production (34) . Furthermore, treatment with antioxidant prevents hydrogen peroxide-induced apoptosis of human umbilical vein endothelial cells in a REDD1-dependent manner (35) . Taken together, these findings highlight the role of REDD1 as a pivotal factor in the cellular defense mechanisms against oxidative stress.
Autophagy is an essential cellular process that maintains organismal homeostasis by degradation and turnover of the defective organelles within the cell. Mounting evidence supports the notion that autophagy is an important regulator of articular cartilage homeostasis and may play a key role in OA pathogenesis (5, 12) . REDD1 regulates autophagy in an mTOR-independent manner involving redox-dependent regulation of ATG-4B, a key enzyme in autophagosome assembly and maturation (18) . In the absence of REDD1, ATG-4B activity is high and prevents the correct processing of LC3, thereby decreasing autophagic flux. In addition to our previous findings that REDD1 is essential for autophagy in articular chondrocytes (10), we showed in the present study that MAP1LC3 and ATG-5 expression is reduced in cartilage from REDD1 2/2 mice and in human chondrocytes with REDD1 knockdown, indicating that REDD1 also regulates autophagy at the transcriptional level. This finding sheds additional light on the mechanisms that regulate autophagy in cartilage and underscores the importance of REDD1 as a regulator of autophagy at multiple levels.
Mitochondrial dysfunction has been well characterized in OA chondrocytes (26, (36) (37) (38) , and alterations in mitochondrial biogenesis have recently been reported in OA (26) . Emerging evidence suggests that REDD1 is a key regulator of mitochondrial integrity and oxidative capacity (39) (40) (41) . REDD1 2/2 murine embryonic fibroblasts exhibited decreased basal oxygen consumption, oxidative ATP generation, and maximal respiratory capacity (18) . Modulation of mitochondrial biogenesis can also be tissue specific and might vary depending on the cellspecific metabolic state (42) . We found large differences in the relative content of mtDNA in spleen, brain, and chondrocytes of REDD1 2/2 mice when compared with wildtype controls, suggesting that REDD1 functions in mitochondrial biogenesis may be tissue dependent.
Since cartilage is an avascular tissue with low oxygen tension (43) , the role of hypoxia in controlling mitochondrial biogenesis might be particularly relevant to cartilage biology. The chief mediator of hypoxic response is the transcription factor hypoxia-inducible factor 1a (HIF-1a) (44) . Although its role in mitochondrial biogenesis has not yet been studied in cartilage, HIF-1a has been reported to regulate mitochondrial biogenesis in adipose tissue (45) , skeletal muscle (46) , and neurons (47) . Since REDD1 is induced by hypoxia in an HIF-1a-dependent manner (48) and basal REDD1 expression is high in articular cartilage under normal conditions, it could be hypothesized that the HIF-1a-REDD1 pathway is a regulator of mitochondrial biogenesis in cartilage. Based on this rationale, it is thus conceivable that the impact of REDD1 deficiency is more severe in articular cartilage than in other tissue.
In this study, we showed that articular chondrocytes from REDD1 2/2 mice have decreased mtDNA content, mitochondrial complex proteins, and ATP levels compared with wild-type littermates. Expression of PGC-1a and TFAM, two regulators of mitochondrial biogenesis, was significantly reduced in the absence of REDD1 in human and mouse chondrocytes, but not in mouse synoviocytes. Importantly, activation of the AMPK-PGC-1a pathway by AICAR required REDD1, which indicates that REDD1 acts downstream of AMPK to transcriptionally regulate PGC-1a expression (Supplementary Figure 3 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/ art.40104/abstract). Thus, the present study provides a novel mechanism whereby REDD1 controls mitochondrial biogenesis in articular chondrocytes.
In summary, our study identifies REDD1 as a novel regulator of autophagy and mitochondrial biogenesis in articular chondrocytes and demonstrates that REDD1 deficiency increases the severity of experimental OA. The present results thus support the notion that the reduced REDD1 expression in human aging and OA-affected joints is a factor that contributes to OA progression and severity. These findings suggest that REDD1 is a central mediator of articular cartilage homeostasis and a potential target for the development of novel therapeutic strategies for OA.
